Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. Operating Income 2015–2022
Corbus Pharmaceuticals Holdings, Inc. annual/quarterly operating income history and growth rate from 2015 to 2022. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Corbus Pharmaceuticals Holdings, Inc. operating income for the quarter ending September 30, 2022 was -8.2 M, a 41.04% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. operating income for the twelve months ending September 30, 2022 was -47.3 M, a 59.74% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual operating income for 2022 was -39.8 M, a 28.85% decrease from 2021.
- Corbus Pharmaceuticals Holdings, Inc. annual operating income for 2021 was -56.0 M, a 54.41% decrease from 2020.
- Corbus Pharmaceuticals Holdings, Inc. annual operating income for 2020 was -122.8 M, a 59.28% increase from 2019.
- Corbus Pharmaceuticals Holdings, Inc. annual operating income for 2019 was -77.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corbus Pharmaceuticals Holdings, Inc. Operating Income — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Corbus Pharmaceuticals Holdings, Inc.'s operating income?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported operating income of -$40M for fiscal 2022.
Where can I see CRBP's operating income history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s operating income by year and by quarter, including the growth rate.